Burns: Clinical Trials

22 trials for Burns, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 422Completed 22

Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oliceridine in Patients With Acute Burn Injuries
Oliceridine, Historical opioid use - Acute Pain, Burns
Phase 4CompletedUniversity of Tennessee312023-04-012023-10-26
Vitamin D Deficiency in Adults Following a Major Burn Injury
Ergocalciferol Capsules - Vitamin D Deficiency, Burns
Phase 4CompletedUniversity of Texas Southwestern Medical Center482022-09-292025-12-15
Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
Platelet Rich Plasma plus fat grafting - Burn
Phase 4CompletedDow University of Health Sciences642021-03-012023-02-21
The Use of a Platform Wound Device for Reducing Infection
Gentamycin with Platform Wound Device - Wounds and Injury, Burn Wound
Phase 4CompletedThe Metis Foundation482021-02-082022-10-14
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
Lidocaine Hydrochloride, Liposomal bupivacaine, Bupivacaine Hydrochloride - Pain, Postoperative, Burns
Phase 4CompletedUniversity of Kansas Medical Center742019-03-182026-03-31
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
Cefazolin, Clindamycin - Burn, Surgery
Phase 4CompletedMedstar Health Research Institute322018-05-292022-08-26
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns
Rheosorbilact®, Ringer lactate - Burns, Intoxication
Phase 4CompletedYuria-Pharm1182017-02-022025-03-10
Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects
Albumins - Burns
Phase 4CompletedUniversity Hospital, Linkoeping302016-10-012019-05-29
TRANexamic Acid to Reduce Bleeding in BURN Surgery
Tranexamic Acid, Placebo - Tranexamic Acid, Burns
Phase 4CompletedCentre Hospitalier Saint Joseph Saint Luc de Lyon1212016-09-222024-04-04
Oxycodone (10, 20 mg) in a Postoperative Dressing
Oxycodone 10mg, Oxycodone 20mg - Burns
Phase 4CompletedPoznan University of Medical Sciences202016-01-012023-11-21
Morphine (10, 20 mg) in a Postoperative Dressing
Morphine Sulfate 10Mg/1mL Injection, Morphine Sulfate 20 MG/ML - Burns
Phase 4CompletedPoznan University of Medical Sciences202016-01-012026-11-12
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
Nanocrystalline silver, Silver Sulfadiazine - Second-degree Burn
Phase 4CompletedUniversity of Sorocaba1002013-11-012021-05-18
Comparison of Wound Bed Establishment in Facial Burns
Enzymatic agent, Bacitracin - Burns
Phase 4CompletedUniversity of Louisville102012-02-012017-08-28
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
water-soluble therapy, silver sulfadiazine - Burn
Phase 4CompletedUniversity of Virginia82011-04-012013-08-21
An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
Wound coverage by acellular skin substitute, Autologous skin - Wound Healing, Scar Formation
Phase 4CompletedMedical University of Vienna182010-11-012011-10-19
Pharmacokinetics Ertapenem Burns
Ertapenem - Burn Patients
Phase 4CompletedNantes University Hospital82010-01-012026-09-14
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
Titanium dioxide - Sunburn
Phase 4CompletedLoreal USA262009-12-012011-06-14
Evaluation of Post Burn Rehabilitation Population for Itch Control
Provase, Control moisturizer - Pruritus, Itching
Phase 4CompletedSwiss-American Products, Inc232006-09-012008-10-29
Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing
ceriumnitrate silversulfadiazine (flammacerium), silversulfadiazine (flammazine) - Burns
Phase 4CompletedAssociation of Dutch Burn Centres1542006-03-012020-02-17
Low-dose Hydrocortisone in Acutely Burned Patients
hydrocortisone 200 mg/day - Burns
Phase 4CompletedHospices Civils de Lyon402005-04-012015-02-12

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Wounds and Injuries (3)  ·  Wound Infection (2)  ·  Acute Pain (1)  ·  Adrenal Insufficiency (1)  ·  Agnosia (1)  ·  Depression (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Facies (1)  ·  Pain, Postoperative (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Pruritus (1)  ·  Respiratory Insufficiency (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Sunburn (1)

Broader conditions

Wounds and Injuries (19)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Neurologic Manifestations (3)  ·  Pathologic Processes (3)  ·  Infections (2)  ·  Pain (2)  ·  Postoperative Complications (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adrenal Gland Diseases (1)  ·  Avitaminosis (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Silver Sulfadiazine (3)  ·  cerous nitrate, sulfadiazine silver drug combination (2)  ·  ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1)  ·  Acticoat (1)  ·  Albumins (1)  ·  Bacitracin (1)  ·  Bupivacaine (1)  ·  Cefazolin (1)  ·  Clindamycin (1)  ·  Ergocalciferols (1)  ·  Ertapenem (1)  ·  Gentamicins (1)  ·  Hydrocortisone (1)  ·  Injections (1)  ·  Lidocaine (1)

Sponsors

Association of Dutch Burn Centres (2)  ·  Poznan University of Medical Sciences (2)  ·  Centre Hospitalier Saint Joseph Saint Luc de Lyon (1)  ·  Dow University of Health Sciences (1)  ·  Hospices Civils de Lyon (1)  ·  Loreal USA (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of Vienna (1)  ·  Medstar Health Research Institute (1)  ·  Nantes University Hospital (1)  ·  Swiss-American Products, Inc (1)  ·  The Metis Foundation (1)  ·  University Hospital, Linkoeping (1)  ·  University of Kansas Medical Center (1)  ·  University of Louisville (1)

Countries

United States (8)  ·  France (3)  ·  Canada (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Brazil (1)  ·  Kazakhstan (1)  ·  Moldova (1)  ·  Pakistan (1)  ·  Sweden (1)  ·  Ukraine (1)  ·  Uzbekistan (1)

Top investigators

Marianne K Nieuwenhuis, PhD (2)  ·  Bernadette Nedelec, BSc, OT, PhD (1)  ·  Carlee R. Lehna, PhD, APRN-BC (1)  ·  Frederick J Stoddard, M.D. (1)  ·  Grzegorz Kowalski, Ph.D. (1)  ·  Joachim Zdolsek, MD,PhD,Assoc prof (1)  ·  Jonathan Black, MD (1)  ·  Katarzyna Wieczorowska-Tobis, Prof.dr hab (1)  ·  Lars P Kamolz, MD, PhD, MSc (1)  ·  Leo LaSalle, M.D. (1)  ·  Luciane C Lopes, PhD (1)  ·  Maike Keck, MD (1)  ·  Maria Pia Kabamalan (1)  ·  Mathieu Fontaine, MD, PhD (1)  ·  Nancy van Loey, PhD (1)

Results publications

PMID 20828761, PMID 22040192, PMID 22842424, PMID 23578794, PMID 23641301, PMID 25619170, PMID 28623938, PMID 32366324, PMID 33350618, PMID 34216466, PMID 34688520, PMID 35141873, PMID 38767196, PMID 39375158